Securing A Path of Accelerated Growth
In 2016, Celltrion also obtained approval by the FDA on the distribution of Remsima in the United States, thereby gaining stability in the land of new opportunities.
Celltrion continues to lead the development of innovative treatments and technologies, including new drugs, vaccines, and biobetters, transforming itself into a world-renowned provider of a comprehensive range of biotechnology and engineering solutions.